HIV isolates resistant to protease inhibitor treatment have an impaired ability to replicate in thymocytes, allowing T-cell production to continue despite the peripheral T-cell decline. Understanding the basis for cellular differences in HIV replication might teach us new ways to protect the immune system from highly pathogenic strains of HIV-1 (pages 712–718).
- Barton F. Haynes
- Gregory D. Sempowski
